share_log

HC Wainwright & Co. Reiterates Buy on Solid Biosciences, Maintains $16 Price Target

Benzinga ·  Dec 12 19:23  · Ratings

HC Wainwright & Co. analyst Arthur He reiterates Solid Biosciences (NASDAQ:SLDB) with a Buy and maintains $16 price target.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment